KKR Genetic Disorder GP LLC (CIK 1780428) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-05-14). Recent activity: Sell BBIO (6.0M shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-05-14 | BridgeBio Pharma, Inc. (BBIO) | 10% Owner | Sell | 6.0M | $205.2M |
来源：SEC Form 4 申报文件 · 截至 2025-05-14